KR20180052157A - Cosmetic composition for whitening skin comprising extract of Sorbus aucuparia berry or fermented product of Sorbus aucuparia berry - Google Patents

Cosmetic composition for whitening skin comprising extract of Sorbus aucuparia berry or fermented product of Sorbus aucuparia berry Download PDF

Info

Publication number
KR20180052157A
KR20180052157A KR1020160148855A KR20160148855A KR20180052157A KR 20180052157 A KR20180052157 A KR 20180052157A KR 1020160148855 A KR1020160148855 A KR 1020160148855A KR 20160148855 A KR20160148855 A KR 20160148855A KR 20180052157 A KR20180052157 A KR 20180052157A
Authority
KR
South Korea
Prior art keywords
cosmetic composition
extract
skin
hole
lotion
Prior art date
Application number
KR1020160148855A
Other languages
Korean (ko)
Other versions
KR102211942B1 (en
Inventor
노윤화
이종성
윤석균
이동걸
박지은
김민지
강승현
김연준
Original Assignee
코스맥스 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 코스맥스 주식회사 filed Critical 코스맥스 주식회사
Priority to KR1020160148855A priority Critical patent/KR102211942B1/en
Publication of KR20180052157A publication Critical patent/KR20180052157A/en
Application granted granted Critical
Publication of KR102211942B1 publication Critical patent/KR102211942B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/85Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

The present invention relates to a cosmetic composition for whitening skin comprising a fermented product of Sorbus commixta fruits obtained by fermenting an extract of Sorbus commixta fruits with lactic acid bacteria as an active ingredient. According to the present invention, the cosmetic composition for whitening skin, which comprises the extract of Sorbus commixta fruits or the fermented product of fermented product of the Sorbus commixta fruits inhibits the gene expression of tyrosinase and microphthalmia-associated transcription factor (MITF) more effectively, and inhibits melanin biosynthesis by promoting liver X Receptor (LXR) activity, and thus in conclusion, a skin whitening effect can be shown.

Description

정공실 추출물 또는 정공실 발효물을 함유하는 피부 미백용 화장료 조성물{Cosmetic composition for whitening skin comprising extract of Sorbus aucuparia berry or fermented product of Sorbus aucuparia berry} TECHNICAL FIELD The present invention relates to a cosmetic composition for skin whitening comprising a fermentation product of a fermentation product,

본 발명은 정공실 추출물 또는 정공실 발효물을 함유하는 피부 미백용 화장료 조성물에 관한 것으로, 더욱 구체적으로 정공실 추출물 또는 정공실 추출물을 유산균을 이용하여 발효한 정공실 발효물을 유효성분으로 함유하는 피부 미백용 화장료 조성물에 관한 것이다.The present invention relates to a skin whitening cosmetic composition containing a hole-sealing material or a hole-sealing material. More specifically, the present invention relates to a cosmetic composition for skin whitening containing a hole-sealing material or a hole-sealing material, To a cosmetic composition for skin whitening.

사람의 피부색을 결정하는 요인들에는 멜라닌, 각질층의 두께, 말초혈관과 혈색소, 카로틴 등이 있지만 이들 중 피부 색깔을 결정하는 가장 중요한 요인은 멜라닌이다. 멜라닌 색소를 생성하는 멜라닌생성세포의 수는 민족이나 피부색에 관계없이 일정하지만, 멜라닌화의 정도, 멜라닌 소체의 크기와 수 그리고 분포상태, 각질형성 세포 내에서의 멜라닌 소체의 분해능 등이 달라서 피부색의 차이가 나타난다. (이승헌 등, 피부 장벽학, 여문각, 2010) The factors determining human skin color include melanin, thickness of stratum corneum, peripheral blood vessels and hemoglobin, and carotene. Of these, melanin is the most important factor in determining skin color. The number of melanin-producing cells that produce melanin pigment is constant irrespective of race or skin color. However, the degree of melaninization, the size and number distribution of melanocytes, and the resolution of melanocytes in keratinocytes are different, There is a difference. (Lee, Seungheon, et al., Skin barrier study, Lemoon, 2010)

멜라닌 생성시에 멜라닌 세포를 감싸는 다양한 환경에 반응하여 그 생합성량이 증가 또는 감소한다. 이러한 조절 구조의 연구는 자외선에 의한 피부의 멜라닌 생성 증가 기전 중심으로 진행되어 왔다. 자외선에 의해 각질형성세포에서 basic fibroblast growth factor (bFGF),alpha-melanocyte stimulating hormone (α-MSH),endothelin-1 (ET-1), prostaglandin E 2 (PGE 2 ) 등의 cytokine이 생성/분비 된다. 이러한 인자들에 반응하는 수용체는 멜라닌 세포의 세포막상에 존재하고, 수용체로부터 전달된 신호는 MITF (Microphthalmia-associated transcription factor)에 영향을 준다. MITF는 LXR (Liver X Receptor)의 영향도 받는데, 발현자체의 조절뿐만 아니라 세포외 신호 조절 인산화 효소(extracellular signal-regulated kinase, ERK) 경로의 활성화에도 영향을 받는다. 핵수용체의 일종인 Liver X receptor (LXR)는 리간드에 의해 활성화되는 핵 수용체로서, 지질 대사 및 콜레스테롤 항상성 유지에 중심 역할을 한다고 알려져 있다. 최근 연구에 의하면 LXR의 활성화가 멜라닌생성세포에서 멜라닌 생합성과정을 억제한다는 보고가 있었다(Lee CS et al., Liver X Receptor Activation Inhibits Melanogenesis through the Acceleration of ERK-Mediated MITF. Degradation J Invest Dermatol., 2013). 또한, LXR 활성화제가 멜라닌 생성을 저해하여 뛰어난 미백효과를 나타낸다는 것이 보고되어 있다(10-2012-0078675 : 간 X 수용체 활성제를 포함하는 피부 미백제).The amount of biosynthesis increases or decreases in response to various environments surrounding melanocytes during melanin production. Studies of this regulatory structure have centered on the mechanism of ultraviolet-induced skin melanogenesis. The cytokines such as basic fibroblast growth factor (bFGF), alpha-melanocyte stimulating hormone (α-MSH), endothelin-1 (ET-1) and prostaglandin E 2 (PGE 2) are produced and secreted by ultraviolet . Receptors that respond to these factors are present on the cell membrane of melanocytes, and the signal from the receptor affects the microphthalmia-associated transcription factor (MITF). MITF is also affected by LXR (Liver X Receptor), which is influenced by the activation of the extracellular signal-regulated kinase (ERK) pathway as well as the expression itself. Liver X receptor (LXR), a nuclear receptor, is a ligand - activated nuclear receptor that is known to play a central role in maintaining lipid metabolism and cholesterol homeostasis. Recent studies have shown that LXR activation inhibits melanin biosynthesis in melanocytes (Lee CS et al., Liver X Receptor Activation Inhibits Melanogenesis through the Acceleration of ERK-Mediated MITF, Degradation J Invest Dermatol., 2013 ). It has also been reported that the LXR activator inhibits melanin production and exhibits an excellent whitening effect (10-2012-0078675: a skin lightening agent containing liver X receptor activator).

전사인자로 작용하는 MITF는 티로시나아제(tyrosinase) 뿐만 아니라 티로시나아제 관련 단백질 1 (tyrosinase related protein 1, TRP-1), 티로시나아제 관련 단백질 2 (tyrosinase related protein 2, TRP-2), DCT (dopachrome tautomerase)와 같은 멜라닌 합성에 관여하는 일련의 효소들의 전사를 유도한다(Saha B et al., Activation of the Mitf promoter by lipid-stimulated activation of p38-stress signalling to CREB. Pigment Cell Res., 2006).  MITF, which acts as a transcription factor, is involved in not only tyrosinase but also tyrosinase related protein 1 (TRP-1), tyrosinase related protein 2 (TRP-2) induces the transcription of a series of enzymes involved in melanin synthesis such as dopachrome tautomerase (Saha B et al., Activation of the MitF promoter by lipid-stimulated activation of p38-stress signaling to CREB. Pigment Cell Res., 2006 ).

생성된 멜라닌 합성효소들은 멜라닌생성세포에서 타이로신(L-tyrosine)을 가수분해시켜 도파(L-dopa), 도파퀴논(L-dopaquinone)으로의 반응을 유발한다. 티로시나아제(tyrosinase)는 이 2개 반응의 촉매가 되는 효소로 미백제로 알려진 하이드로퀴논, 알부틴 같은 물질이 반응을 방해하여 멜라닌 생성을 억제하는 것으로 미백 효과를 가져온다. 생성된 도파퀴논(L-dopaquinone)은 DCT (dopachrome tautomerase), TRP-1 (tyrosinase related protein 1), TRP-2 (tyrosinase related protein 2)의 일련의 효소 작용을 거쳐 흑색의 유멜라닌(Eumelanin)으로 합성된다. The resulting melanin synthases hydrolyze tyrosine (L-tyrosine) in melanin-producing cells, leading to reactions to L-dopa and L-dopaquinone. Tyrosinase is an enzyme that catalyzes these two reactions, and substances such as hydroquinone and arbutin, which are known as whitening agents, interfere with the reaction, thereby inhibiting melanin production, resulting in a whitening effect. The resulting dopaquinone is converted to black eumelanin by a series of enzymatic actions of DCT (dopachrome tautomerase), TRP-1 (tyrosinase related protein 1) and TRP-2 (tyrosinase related protein 2) Are synthesized.

한편, 정공실(Sorbus Aucuparia Berry)은 장미과에 속하는 낙엽활엽소교목인 마가목의 열매로써, 가을에 붉게 익은 것을 채취하여 햇볕에 말려 사용한다. 시큼한 맛의 정공실은 기침과 가래에 특효약이다. 종래의 연구에서 마가목의 줄기 및 수피의 미백 효능에 대하여 밝혔으나(10-2005-0110149 : 마가목 추출물을 함유하는 화장료 조성물), 마가목의 열매인 정공실에 대한 미백 효과는 어디에도 기재되어 있지 않다. On the other hand, the hole thread (Sorbus Aucuparia Berry ) is a fruit of the fallen leaves of the fallen leaves, belonging to the Rosaceae. It is harvested in autumn and used in the sun. The sour taste of the hallucinos is a cure for cough and sputum. Previous studies have revealed whitening efficacy of the trunks and bark of the legs (10-2005-0110149: cosmetic composition containing the legume extract), but no whitening effect on the ear shell, which is the fruit of the legs, is described at all.

이에, 본 발명자들은 상기 종래기술들의 문제점들을 극복하기 위하여 예의 연구노력한 결과, 마가목의 열매인 정공실만을 이용하여 발효공법을 거쳐 기존의 마가목 추출물(수피 및 줄기)보다 뛰어난 정공실 발효물을 확보할 수 있었으며, 이를 이용한 피부 미백용 화장료 조성물의 경우, 티로시나아제(tyrosinase) 발현 억제 및 멜라닌 생합성을 억제함으로써 피부 미백효과를 나타낼 수 있음을 확인하고, 본 발명을 완성하게 되었다.Accordingly, the present inventors have made intensive researches to overcome the problems of the prior art, and as a result, they have found that a fermentation process using only a positive-working chamber, which is a fruit of a rowan, And it was confirmed that the cosmetic composition for skin whitening using the same can exhibit a skin whitening effect by inhibiting tyrosinase expression and inhibiting melanin biosynthesis, thereby completing the present invention.

KRKR 10-2005-011014910-2005-0110149 AA

따라서, 본 발명의 주된 목적은 티로시나아제(tyrosinase) 발현 억제 및 멜라닌 생합성을 억제함으로써 피부 미백효과를 갖는 정공실 추출물 또는 정공실 발효물을 함유하는 피부 미백용 화장료 조성물을 제공하는 데 있다.Accordingly, it is a main object of the present invention to provide a cosmetic composition for skin whitening comprising a hole-sealer extract or a hole-sealer fermented product having a skin whitening effect by inhibiting tyrosinase expression and inhibiting melanin biosynthesis.

본 발명의 한 양태에 따르면, 본 발명은 정공실 추출물 또는 정공실 발효물을 유효성분으로 함유하는 피부 미백용 화장료 조성물을 제공한다.According to one aspect of the present invention, there is provided a skin whitening cosmetic composition comprising as an active ingredient an extract of a hole-sealing material or a fermentation product of a hole-sealing material.

정공실(Sorbus Aucuparia Berry)은 장미과에 속하는 낙엽활엽소교목인 마가목의 열매로써, 종래에 화장료로 이용되던 마가목의 줄기와 수피의 추출물, 즉 마가목 추출물과는 구별된다. 본 발명자들은 마가목의 줄기와 수피에 비해 열매인 정공실의 멜라닌 생성억제능이 높음을 확인하였고, 더욱이 이를 발효과정을 거친 정공실 발효물의 경우, 티로시나아제 및 멜라닌 생합성 억제가 마가목 수피 및 줄기 추출물, 및 정공실 추출물보다 높아 더 우수한 피부 미백 효과를 나타낼 수 있음을 확인하고, 본 발명을 완성하게 되었다. Hole chamber ( Sorbus Aucuparia Berry ) is a fruit of the broad-leaved broadleaf tree belonging to the rose family. It is distinguished from the stem and bark extracts of the legs , which were conventionally used as cosmetics. The inventors of the present invention have confirmed that melanin production inhibitory ability of the positive hole, which is a fruit, is higher than that of the trunk and bark of the legs. In addition, in the case of fermented yeast fermented product, inhibition of biosynthesis of tyrosinase and melanin, And the extract of the hole-sealing material, thus showing a superior skin-whitening effect. Thus, the present invention has been completed.

본 발명에 있어서, 상기 정공실 추출물은 종래에 식물, 생약, 열매 추출을 위해 사용되어진 어떠한 용매로도 추출될 수 있으며, 바람직하게는 물, 탄소수 1 내지 4의 저급알코올, 글리세린, 에틸아세테이트, 부틸렌글리콜, 프로필렌글리콜, 디클로로메탄 또는 핵산으로 추출하는 것을 특징으로 한다.In the present invention, the above-mentioned hole-chamber extract can be extracted with any solvent conventionally used for extracting plants, herbal medicines and fruits, preferably water, lower alcohol having 1 to 4 carbon atoms, glycerin, ethyl acetate, butyl Propylene glycol, dichloromethane, or a nucleic acid.

상기 추출용매를 이용한 추출방법으로는 통상적인 식물의 추출방법 예를 들면, 에탄올 추출, 환류냉각 추출, 초음파 추출, 초임계 추출 등의 방법을 사용할 수 있으며, 본 발명의 실시예에서는 열수 추출물을 설명하고 있으나, 이에 한정되지는 않을 것이다. As the extraction method using the above-mentioned extraction solvent, conventional methods of extracting plants such as ethanol extraction, reflux cooling extraction, ultrasonic extraction and supercritical extraction can be used. In the embodiment of the present invention, But is not limited to this.

본 발명에 있어서, 상기 정공실 발효물은 정공실 추출물을 유산균으로 발효한 것을 특징으로 한다.In the present invention, the fermentation product of the positive-working chamber is characterized in that the fermentation of the positive-working chamber extract is carried out with lactic acid bacteria.

본 명세서에서 "발효"라 함은 미생물이 자신이 가지고 있는 효소를 이용해 유기물을 분해 시키는 과정을 의미한다. 발효는 본 발명 기술 분야에 알려져 있는 통상의 방법을 선정하거나 그로부터 응용하여 이루어질 수 있으며, 예를 들어 30℃ 내지 45℃, 구체적으로 35℃ 내지 38℃에서 30시간 내지 140시간, 구체적으로 110시간 내지 130시간 동안 이루어질 수 있다. 이와 같은 발효를 통해 정공실 발효물의 피부 미백 효과가 더 높아 질 수 있다.In the present specification, the term "fermentation" means a process in which a microorganism decomposes an organic substance using an enzyme contained therein. The fermentation may be carried out by selecting or applying the conventional methods known in the art of the present invention. For example, the fermentation may be carried out at a temperature of 30 ° C to 45 ° C, specifically 35 ° C to 38 ° C for 30 hours to 140 hours, 130 hours. Through such fermentation, the skin whitening effect of the fermentation product of the hole furnace can be further enhanced.

본 발명에 있어서, 정공실 발효물은 정공실 추출물을 미생물로 발효시킨 발효물을 의미한다. 상기 미생물은 유산균(lactic acid bacteria)일 수 있으며, 바람직하게는 락토바실러스(Lactobacillus sp.), 류코노스톡(Leuconostoc sp.) 또는 비피도박테리아(Bifidobacteria sp.)인 것을 특징으로 하나, 이에 제한되는 것은 아니다. In the present invention, the fermentation product of the positive-working chamber refers to a fermentation product obtained by fermenting the positive-working-chamber extract with a microorganism. The microorganism may be a lactic acid bacteria, preferably Lactobacillus sp., Leuconostoc sp. Or Bifidobacteria sp., But is not limited thereto. It is not.

본 발명에 있어서, 상기 정공실 추출물 또는 정공실 발효물은 화장료 조성물 총 중량 대비 0.01 내지 90중량% 함유하는 것을 특징으로 한다. 상기의 범위를 벗어나는 경우에는 제형화가 용이하지 않아 바람직하지 않다. In the present invention, the above-mentioned hole-chamber extract or fermented product of the hole-sealing material contains 0.01 to 90% by weight based on the total weight of the cosmetic composition. If it is outside the above range, formulation is not easy and it is not preferable.

본 발명에 있어서, 상기 조성물은 티로시나아제(tyrosinase) 발현 억제 및 멜라닌 생합성을 억제함으로써 피부 미백효과를 나타내는 것을 특징으로 한다. In the present invention, the composition is characterized by exhibiting a skin whitening effect by inhibiting tyrosinase expression and inhibiting melanin biosynthesis.

본 발명의 실험예에 따르면, 정공실 추출물은 마가목 줄기와 수피 추출물보다 멜라닌 생성 억제율이 높고, 멜라닌 생성 세포에서 멜라닌의 양을 농도 의존적으로 감소시켰으며, 티로시나아제 발현 또한 농도 의존적으로 억제하는 것을 확인할 수 있다. 이러한 결과로 볼 때, 본 발명의 정공실 추출물을 이용한 발효물도 티로시나아제 및 멜라닌 합성을 억제함으로써 피부 미백 효과를 나타낼 수 있음을 의미한다(실험예3-5 참조). According to the experimental example of the present invention, the positive-working chamber extract has a higher inhibitory rate of melanin production than the raspberry stem and bark extract, decreases the amount of melanin in a melanin-producing cell in a concentration-dependent manner, and inhibits tyrosinase expression in a concentration- Can be confirmed. These results indicate that the fermented product of the present invention can inhibit the synthesis of tyrosinase and melanin, thereby exhibiting a skin whitening effect (see Experimental Example 3-5).

또한, 본 발명의 실험예에 따르면, 정공실 발효물은 발효를 거치지 않은 정공실 추출물보다 더 많이 멜라닌 생성 세포에서 멜라닌의 양을 농도 의존적으로 감소시켰으며, 티로시나아제 발현 또한 농도 의존적으로 억제하는 것을 확인할 수 있다. 이러한 결과로 볼 때, 본 발명의 정공실 발효물이 발효를 하지 않은 정공실 추출물보다 효과적으로 티로시나아제 및 멜라닌 합성을 억제함으로써 더 우수한 피부 미백 효과를 나타낼 수 있음을 의미한다(실험예3-5 참조). In addition, according to the experimental example of the present invention, the fermented product of the positive-working chamber decreased the amount of melanin in the melanin-producing cells in a concentration-dependent manner more than that of the fermented untreated positive-working chamber extract and inhibited tyrosinase expression in a concentration- . These results indicate that the fermented product of the present invention can inhibit the synthesis of tyrosinase and melanin more effectively than the fermented non-fermented airtight chamber extract (Example 3-5 Reference).

더욱이, 본 발명의 정공실 발효물은 티로시나아제 및 DCT(dopachrome tautomerase)의 단백질 발현을 저해함으로써 피부 멜라닌 합성을 억제하는데, 구체적으로는, 정공실 발효물과 정공실 추출물은 멜라닌 생성에 관여하는 유전자인 티로시나아제, DCT의 발현을 모두 감소시키는 것을 확인할 수 있었으며, 정공실 추출물보다 정공실 발효물이 더 효과적으로 티로시나아제 및 DCT 발현을 감소시키는 것을 확인하였다. 이러한 결과로 볼 때, 본 발명의 정공실 발효물은 상기 유전자들의 억제를 통하여 티로시나아제를 억제할 수 있으며 결과적으로 피부 미백 효과를 나타낼 수 있음을 의미한다(실험예 6 참조). Furthermore, the fermented product of the present invention inhibits skin melanin synthesis by inhibiting the protein expression of tyrosinase and DCT (dopachrome tautomerase). Specifically, the fermented product of the positive-working chamber and the positive-working chamber is involved in the production of melanin Tyrosinase, and DCT, respectively, and it was confirmed that the fermentation of the hole-sealed cells decreased the expression of tyrosinase and DCT more effectively than that of the hole-chamber extract. These results indicate that the fermented yeast of the present invention can inhibit tyrosinase through inhibition of the genes, resulting in skin whitening (see Experimental Example 6).

본 발명에 있어서, 상기 조성물은 스킨로션, 스킨소프너, 스킨토너, 아스트린젠트, 로션, 밀크로션, 모이스쳐 로션, 영양로션, 맛사지크림, 영양크림, 모이스처크림, 핸드크림, 파운데이션, 에센스, 영양에센스, 팩, 비누, 클렌징폼, 클렌징로션, 클렌징크림, 바디로션 및 바디클렌저로 구성된 그룹에서 선택된 하나 이상의 제형인 것을 특징으로 한다. 예를 들면 유연화장수, 수렴화장수, 영양화장수, 영양크림, 마사지크림, 에센스, 아이크림, 아이에센스, 클렌징크림, 클렌징폼, 클렌징워터, 팩, 파우더, 보디로션, 보디크림, 보디오일, 보디에센스 등의 화장료 제형을 가질 수 있으며 또한 로션, 연고, 겔, 크림, 패취 또는 분무제와 같은 경피투과형 제형을 갖는 화장료 조성물 일 수 있다. 본 발명의 화장품 조성물은 담체 이외에 다른 보조제를 포함할 수 있는데, 예를 들면 보존제, 항산화제, 안정화제, 용해화제, 비타민, 안료 및 향료 등을 포함할 수 있다.In the present invention, the composition may be used as a skin lotion, a skin softener, a skin toner, an astringent, a lotion, a milk lotion, a moisturizing lotion, a nutrition lotion, a massage cream, a nutritional cream, a moisturizing cream, a hand cream, , A soap, a cleansing foam, a cleansing lotion, a cleansing cream, a body lotion and a body cleanser. For example, softening longevity, convergent lotion, nutritional lotion, nutritional cream, massage cream, essence, eye cream, eye essence, cleansing cream, cleansing foam, cleansing water, pack, powder, body lotion, body cream, body oil, body essence , And may also be a cosmetic composition having transdermal delivery formulations such as lotions, ointments, gels, creams, patches or sprays. The cosmetic composition of the present invention may contain other adjuvants in addition to the carrier, for example, preservatives, antioxidants, stabilizers, solubilizers, vitamins, pigments and perfumes.

이상 설명한 바와 같이, 정공실 추출물 또는 정공실 추출물을 유산균을 이용하여 발효한 정공실 발효물은 티로시나아제, DCT의 발현을 억제하고 멜라닌 생성세포에서 멜라닌의 생성을 억해함으로써 피부 미백 효과를 나타낸다. As described above, the fermented yeast cells obtained by fermenting the extracts of the positive-pressure chamber or the positive-working chamber with lactic acid bacteria inhibit the expression of tyrosinase or DCT and inhibit the production of melanin in the melanin-producing cells.

도 1 은 마가목 줄기 추출물과 정공실 추출물에 의한 멜라닌 생석 억제 효과를 사람 색소세포(Human epidermal melanocyte)에서 관찰한 결과이다.
도 2 는 정공실 발효물이 정공실 추출물보다 높은 멜라닌 생성 억제효과를 나타냄을 관찰한 결과이다.
도 3 은 정공실 발효물이 정공실 추출물보다 티로시나아제의 발현 억제율이 높음을 관찰한 결과이다.
도 4 은 정공실 발효물이 정공실 추출물보다 DCT의 발현 억제율이 높음을 관찰한 결과이다.
Fig. 1 shows the results of human melanocyte-induced inhibition of melanin secretion by the extracts of Rumexii and Saccharomyces cerevisiae.
FIG. 2 shows a result of observing that the fermented product of the positive-working chamber exhibits a higher inhibitory effect on the melanin formation than the positive-working chamber extract.
FIG. 3 shows the result of observing that the fermented product of the positive-working chamber has a higher rate of suppression of tyrosinase expression than the positive-working chamber extract.
FIG. 4 shows the results of observing that the fermented product of the positive-working chamber has a higher inhibitory rate of DCT expression than the positive-working chamber extract.

이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하기로 한다. 이들 실시예는 단지 본 발명을 예시하기 위한 것이므로, 본 발명의 범위가 이들 실시예에 의해 제한되는 것으로 해석되지는 않는다.Hereinafter, the present invention will be described in more detail with reference to Examples. These embodiments are only for illustrating the present invention, and thus the scope of the present invention is not construed as being limited by these embodiments.

비교예Comparative Example 1:  One: 정공실Hole chamber 추출물의 제조 Preparation of extract

정공실은 한의원에 약제를 전문적으로 납품하는 동양허브라는 전문업체에서 구입하여 본 발명의 시료로 사용하였다. It was purchased from a specialized company called Oriental Herb which is specialized in delivering medicines to Oriental Medical Clinic and used as a sample of the present invention.

정공실 추출물을 제조하기 위해 100 g의 정공실을 흐르는 물에 세척하여 자연 건조시킨 뒤 파쇄기를 사용하여 열매를 일부 파쇄하고, 착즙기를 사용하여 압착 추출을 실시하였다. 추출된 정공실 추출물은 멸균을 위해 0.2 um 주사기 필터를 사용하여 멸균 처리하였다. In order to prepare the hole chamber extract, 100 g of the positive hole was washed with flowing water, dried naturally, partially crushed by a crusher, and subjected to compression extraction using a juicer. The extracts were sterilized using a 0.2 μm syringe filter for sterilization.

비교예 2: 마가목 줄기 및 수피 추출물의 제조COMPARATIVE EXAMPLE 2: Preparation of Rectal Stem and Bark Extract

마가목 줄기 및 수피는 한의원에 약제를 전문적으로 납품하는 동양허브라는 전문업체에서 구입하여 본 발명의 시료로 사용하였다. Rice stalks and bark were purchased from a specialized company called Oriental Herb, which professionally delivers medicines to the oriental clinic, and used as a sample of the present invention.

마가목 추출물을 제조하기 위해 100 g의 마가목 줄기 및 수피를 흐르는 물에 세척하여 자연 건조시킨 뒤 파쇄기를 사용하여 일부 파쇄하고, 착즙기를 사용하여 압착 추출을 실시하였다. 추출된 마가목 추출물은 멸균을 위해 0.2 um 주사기 필터를 사용하여 멸균 처리하였다. In order to prepare Rake Extract, 100 g of Rake stems and bark were washed with running water, air dried, partially crushed using a crusher, and compressed by a juicer. Extracted Rectal Extracts were sterilized using a 0.2 um syringe filter for sterilization.

실시예 1: 정공실 발효물(F-SAF)의 제조Example 1: Preparation of a fermentation product of a positive hole (F-SAF)

정공실은 한의원에 약제를 전문적으로 납품하는 동양허브라는 전문업체에서 구입하여 본 발명의 시료로 사용하였다. It was purchased from a specialized company called Oriental Herb which is specialized in delivering medicines to Oriental Medical Clinic and used as a sample of the present invention.

정공실 발효물은 비교예 1(정공실 추출물)을 넣은 액체 배지에 락토바실러스 (Lactobacillus sp. CXHB-4)를 107-109 cell/mL로 접종하고, 5 일(120hr)간 배양을 실시하고, pH 6.5~7.5, 온도 35~38℃, 통기량 1VVM의 조건을 유지하면서 배양하였다. 상기 발효액을 10000 Xg에서 30분간 원심분리하여 고분자 침전물과 균체가 제거된 최종 정공실 발효물을 얻었다.The fermented product of the positive-working chamber was inoculated with 10 7 -10 9 cells / mL of Lactobacillus sp. CXHB-4 in a liquid medium containing Comparative Example 1 (the hole-sealing material extract) and cultured for 5 days (120 hr) , And the cells were cultured while maintaining the conditions of pH 6.5 to 7.5, temperature 35 to 38 ° C, aeration amount 1 VVM. The fermentation broth was centrifuged at 10,000 xg for 30 minutes to obtain a final fermentation product in which the polymer precipitate and microbial cells were removed.

실험예 1: 정공실 추출물에 의한 인체멜라닌 세포의 멜라닌 생성 억제효과 측정Experimental Example 1: Measurement of melanin production inhibitory effect of human melanocytes by the hole-chamber extract

인체 멜라닌세포(melanocyte)를 이용하여 정공실 추출물(비교예 1)과 마가목 줄기 및 수피 추출물(비교예 2)에 의한 멜라닌 생성 억제효과를 측정하고, 이를 멜라닌 생성을 억제하는 것으로 알려진 H89(10uM)에 의한 멜라닌 생성 억제효과와 비교하였다.The inhibitory effect of melanocyte on human melanocytes was examined by using the positive-pressure-room extract (Comparative Example 1), Rake Stem and Bark Extract (Comparative Example 2), and H89 (10 uM), which is known to inhibit melanin production, To inhibit melanin production.

본 실험은 Cascade Biologics사로부터 구입한 Human epidermal melanocyte (신생아유래) 세포를 역시 같은 회사에서 구입한 Human Melanocyte Growth supplement를 포함한 Medium 254배지에서 배양한다. Human epidermal melanocytes를 6-well plate에 well당 1× 105 개로 접종한 후 5 % CO2, 37℃ 하에서 세포가 well 바닥에 약 80 % 이상 부착될 때까지 배양하였다. 배양 후 배지를 제거하고 시료를 적당 농도로 희석하여 배지에 처리한 후 5% CO2, 37℃ 하에서 이틀에 한 번 배지를 갈아주면서 5일간 배양하였다. 추출물의 농도범위는 세포독성이 없는 10㎍/㎖, 50㎍/㎖로 결정하였다. 처리가 끝난 후 배지를 제거하고 PBS(phosphated buffer saline)로 세척한 후, 트립신으로 처리하여 세포를 회수하였다. 회수된 세포는 hematocytometer를 이용하여 세포수를 측정한 후 각 처리 그룹별 세포수를 동수로 맞추어 5,000 ~ 10,000 rpm으로 10분간 원심 분리한 다음 상등액을 제거하여 세포를 얻었다. 이 세포를 60℃에서 건조한 후, 10% DMSO가 함유된 1M 수산화나트륨액 100㎕를 넣어 60℃ 항온조에서 세포내 멜라닌을 얻었다. 이 액으로 microplate reader로 490㎚에서 흡광도를 측정하여 세포 일정 수당 멜라닌 양을 구하였다. 그 결과를 하기 도 1에 나타내었다. The human epidermal melanocyte cells (obtained from Cascade Biologics) were cultured in Medium 254 medium containing Human Melanocyte Growth supplement purchased from the same company. Human epidermal melanocytes were inoculated in a 6-well plate at 1 × 10 5 cells per well and cultured at 37 ° C in 5% CO 2 until cells were attached to the bottom of the wells at about 80%. After the culture, the medium was removed, the sample was diluted to a proper concentration, treated with the medium, and incubated at 37 ° C in 5% CO 2 for 5 days while changing the medium every other day. The concentration range of the extract was determined to be 10 μg / ml, 50 μg / ml without cytotoxicity. After the treatment, the medium was removed, washed with PBS (phosphatized buffer saline), and treated with trypsin to recover the cells. The recovered cells were counted using a hematocytometer, centrifuged at 5,000 ~ 10,000 rpm for 10 minutes, and the supernatant was removed to obtain cells. The cells were dried at 60 ° C., and 100 μl of a 1 M sodium hydroxide solution containing 10% DMSO was added thereto to obtain intracellular melanin in a 60 ° C. thermostatic chamber. Absorbance was measured at 490 nm with a microplate reader to determine the amount of melanin per cell constant. The results are shown in Fig.

도 1에 나타난 바와 같이, 인체 멜라닌 세포에서 비교예 1인 정공실 추출물 처리에 의한 멜라닌 양이 농도 의존적으로 감소됨을 확인하였다. 반면에 마가목 줄기 및 수피 추출물인 비교예 2의 경우, 멜라닌의 생성억제 효과가 있지만, 비교예 1인 정공실 추출물 비해 억제율이 낮음을 확인할수있었다. 그러므로, 정공실 추출물이 인체 세포에도 미백 효능을 나타내고 있음을 확인하였다. As shown in FIG. 1, it was confirmed that the amount of melanin in the human melanocytes was reduced in a concentration-dependent manner by the treatment with the extract of the hole chamber of Comparative Example 1. On the other hand, Comparative Example 2, which is a trunk extract and bark extract, showed an inhibitory effect on the production of melanin, but the inhibition rate was lower than that of Comparative Example 1. Therefore, it was confirmed that the extract of the hole-sealing material has a whitening effect on human cells.

실험예 2: 정공실 추출물의 Liver X Receptor Response Element(LXRE) 프로모터 활성 촉진 효과EXPERIMENTAL EXAMPLE 2 Promotion of Promoter Activity of Liver X Receptor Response Element (LXRE)

멜라닌 양을 감소시키는 정공실 추출물의 억제 메카니즘을 규명하기 위한 실험을 수행하였다. Liver X receptor(LXR)가 활성화 되면, 멜라닌 생성이 억제된다고 보고되어 있어 LXR 단백질에 의해 활성화된 LXRE 프로모터를 이용하여, 정공실 추출물이 LXRE 프로모터 리포터(LXRE promoter luciferase reporter)를 활성화 시킬 수 있는지의 여부를 조사하였다. LXRE reporter DNA를 murine melanoma(B-16 F10) 세포에 superfect를 이용하여 삽입함으로써, 형질전환을 유도하였고, 형질전환된지 24시간 후에 추출물을 처리하였다. 16시간이 경과된 후에 세포를 수집하고, Luminometer (Berthold, Germany)를 이용하여 450㎚에서 luminescence를 측정하였다. (Planta medica 2005; 71:338-343) 양성대조군으로 LXR의 활성화제로 알려진 TO901317을 사용하였다. 그 결과를 하기 표 1에 나타내었다.Experiments were conducted to investigate the mechanism of suppression of the hole - chamber extract which reduces the amount of melanin. It has been reported that activation of the liver X receptor (LXR) inhibits melanogenesis, and it is possible to determine whether the LXRE promoter activated by the LXR protein can activate the LXRE promoter luciferase reporter Respectively. Transfection was induced by inserting LXRE reporter DNA into murine melanoma (B-16 F10) cells using superfect, and the extract was treated 24 hours after transformation. After 16 hours, the cells were collected and luminescence was measured at 450 nm using a Luminometer (Berthold, Germany). (Planta medica 2005; 71: 338-343). As a positive control, TO901317 known as activator of LXR was used. The results are shown in Table 1 below.

시료sample 처리농도 Treatment concentration Relative luciferase activityRelative luciferase activity 무처리군Untreated group 1007.5±14.51007.5 + 14.5 양성대조군 - T0901317Positive control - T0901317 20uM 20uM 3932.5±90.53932.5 ± 90.5 비교예 1 - 정공실 추출물Comparative Example 1 - 10㎍/㎖10 mu g / ml 1181.2±24.91181.2 + - 24.9 비교예 1 - 정공실 추출물Comparative Example 1 - 50㎍/㎖50 mu g / ml 1331.5±53.11331.5 ± 53.1 비교예 2 - 마가목 줄기 및 수피 추출물Comparative Example 2 - Rectal stem and bark extract 10㎍/㎖10 mu g / ml 1061.9±8.01061.9 ± 8.0 비교예 2 - 마가목 줄기 및 수피 추출물Comparative Example 2 - Rectal stem and bark extract 50㎍/㎖50 mu g / ml 1076.2±43.51076.2 + - 43.5

표 1에서 나타나는 바와 같이, 마가목이라도 부위에 따라 그 효능효과가 다름을 관찰할 수 있었는데, 마가목의 줄기 및 수피 추출물인 비교예 2의 경우 LXR 단백질의 활성화 효과가 없는 반면, 마가목의 열매인 정공실 추출물, 비교예 1의 경우 LXR 단백질을 농도 의존적으로 활성화시킴을 관찰하였다. 그러므로, 본 실험을 통해 정공실이 뛰어난 미백 효능을 가지고 있음을 증명하였다.As shown in Table 1, it was observed that the efficacy was different depending on the site of the bean curd. In the case of the stem and bark extract of the bean curd, Comparative Example 2 had no activation effect of the LXR protein, In the case of the extract, Comparative Example 1, LXR protein was activated in a concentration-dependent manner. Therefore, through this experiment, it was proved that the positive hole has an excellent whitening effect.

실험예 3: 정공실 발효물에 의한 색소 세포의 멜라닌 생성 억제효과 측정Experimental Example 3: Measurement of inhibitory effect on melanin formation of pigment cells by fermentation of a hole-sealed chamber

쥐의 색소세포(B16 melanoma cells)를 이용하여 비교예 1 및 실시예 1에 의한 멜라닌 생성 억제효과를 측정하였으며, 이를 멜라닌 생성을 억제하는 것으로 알려진 알부틴(100 ppm)에 의한 멜라닌 생성 억제효과와 비교하였다.The inhibitory effect of melanin production by Comparative Example 1 and Example 1 was measured using mouse melanoma cells (B16 melanoma cells) and compared with the effect of inhibiting melanin formation by arbutin (100 ppm), which is known to inhibit melanin production Respectively.

본 실험은 murine melanoma(B16 F10) 세포를 10% FBS를 포함하는 DMEM에 현탁시켜 well당 1 × 105 cells 으로 6-well plate에 접종하여 well 바닥에 부착될때까지 배양한다. 멜라닌 생성 유도를 위하여 0.1uMα-MSH를 처리하고, 이후 시료를 농도별로 첨가한 후 3일간 배양하였다. 물질 처리의 농도범위는 0.1%, 1% 로 설정하였다. 멜라닌 생성능 실험의 양성대조군으로 알부틴 100 ppm 을 처리하였다. 배양한 세포는 phosphate buffered saline(PBS)으로 씻고 트립신(trypsin)으로 회수하였다. 회수한 세포를 혈구계(hematocytometer)로 계수하여 각 처리 그룹별로 1× 106 cells/mL 으로 동일한 세포수가 되도록 모아 1000rpm, 10분간 원심분리하여 세포만을 얻었다. 회수된 세포를 60℃에서 1시간 건조시켜 10% DMSO가 포함된 1M NaOH용액 100 ㎕을 넣어 세포내의 멜라닌을 얻었다. 이 멜라닌 액을 Microplate reader로 490nm에서 흡광도를 측정하여 멜라닌 생성 저해율을 평가하였다. 그 결과를 하기 도 2에 나타내었다. In this experiment, murine melanoma (B16 F10) cells were suspended in DMEM containing 10% FBS, and inoculated on a 6-well plate at 1 × 10 5 cells per well, and cultured until adhered to the well bottom. For the induction of melanin production, 0.1 μM α-MSH was added, and then samples were added at different concentrations and cultured for 3 days. The concentration range of the material treatment was set at 0.1% and 1%. As a positive control for melanin production, arbutin was treated at 100 ppm. The cultured cells were washed with phosphate buffered saline (PBS) and recovered with trypsin. The recovered cells were counted with a hematocytometer and collected at 1 × 10 6 cells / mL for each treatment group, and centrifuged at 1000 rpm for 10 minutes to obtain cells. The recovered cells were dried at 60 ° C for 1 hour, and 100 μl of a 1 M NaOH solution containing 10% DMSO was added to obtain melanin in the cells. The melanin inhibition rate was evaluated by measuring the absorbance at 490 nm using a microplate reader. The results are shown in Fig.

도 2에서 나타나는 바와 같이, 물질 처리에 의해 멜라닌 양이 농도 의존적으로 감소함을 관찰하였다. 특히, 실시예 1의 경우, 알부틴에 비해 우수한 미백효능을 보였다. 그러므로, 본 실험을 통해 정공실 발효물이 가장 뛰어난 미백 효능을 가지고 있음을 증명하였다.As shown in FIG. 2, it was observed that the amount of melanin was decreased in a concentration-dependent manner by the treatment with the substance. In particular, in Example 1, whitening efficacy was superior to that of arbutin. Therefore, it was proved through this experiment that the fermentation product of the hole-sealing material has the most excellent whitening effect.

실험예 4: 정공실 발효물에 의한 세포내 티로시나아제 유전자 발현 측정Experimental Example 4: Measurement of intracellular tyrosinase gene expression by a fermentation product

쥐의 색소세포(B16 melanoma cells)를 이용하여 비교예 1 및 실시예 1에 의한 멜라닌 생성에 중요한 효소인 티로시나아제의 발현 억제효과를 확인하였다. The inhibitory effect of tyrosinase, an enzyme important for melanin production, in Comparative Example 1 and Example 1 was confirmed by using mouse pigment cells (B16 melanoma cells).

본 실험은 murine melanoma(B-16 F1) 세포를 10%의 FBS (fetal bovine serum)가 함유된 DMEM 배지로 6-well plate에 well 당 5× 105 개로 접종한 후 5% CO2, 37℃ 하에서 세포가 well 바닥에 약 80 % 이상 부착될 때까지 배양하였다. 멜라닌 생성 유도를 위하여, 0.1 uM α-MSH를 처리하고, 이후 시료를 1% 첨가한 후 24시간 배양하였다. 양성대조군으로 알부틴 100 ppm 을 처리하였다. 배양한 세포는 phosphate buffered saline으로 씻고 1 ㎖ Trizol을 넣어 회수하였다. 0.2㎖ Chloroform(Trizol의 1/5 비율)을 넣어 voltexing 하여 4℃에서 14000rpm, 15 분간 원심분리로 상층액을 얻었다. 동 상층액에 0.5 ㎖ isopropanol 넣고 10분간 반응시킨 후, 14000 rpm, 15 분간 원심분리하여 침전물을 얻었다. 상층액을 제거하고 200 ㎕ 100% EtOH를 이용하여 2회 씻어준다. 이후 침전물을 상온에서 완전히 말려 DEPC water 20~30 ㎕ 에 녹였다. DEPC에 녹인 RNA를 정량하여 각 그룹 당 RNA 동량을 사용하여 cDNA를 합성하였다. 합성된 cDNA를 타겟으로 시아닌 염료인 SYBR GREEN master mix 를 사용하여 실시간 중합효소 연쇄반응 (PCR)을 실시하여 최종적으로 tyrosinase의 유전자 발현 정도를 평가하였다. 그 결과를 하기 도 3에 나타내었다. This experiment murine melanoma (B-16 F1) were inoculated the cells of 10% of FBS (fetal bovine serum) is the 6-well plate in the DMEM medium 5 × 10 5 pieces per well 5% CO 2, 37 ℃ Were cultured under the condition that the cells were attached to the bottom of the well by about 80% or more. For the induction of melanin production, 0.1 μM α-MSH was treated, followed by addition of 1% sample, followed by incubation for 24 hours. As a positive control, 100 ppm of arbutin was treated. The cultured cells were washed with phosphate buffered saline and recovered by adding 1 ml of Trizol. The mixture was subjected to voltexing by adding 0.2 ml of chloroform (1/5 ratio of Trizol), and the supernatant was obtained by centrifugation at 4 ° C and 14,000 rpm for 15 minutes. 0.5 ml of isopropanol was added to the supernatant, followed by reaction for 10 minutes, followed by centrifugation at 14000 rpm for 15 minutes to obtain a precipitate. The supernatant is removed and washed twice with 200 μl of 100% EtOH. The precipitate was then completely dried at room temperature and dissolved in 20 to 30 μl of DEPC water. RNA was dissolved in DEPC and cDNA was synthesized using the same amount of RNA per group. The synthesized cDNA was used as a target and cyanogen dyes SYBR GREEN master mix was used to perform real - time PCR (PCR). Finally, gene expression of tyrosinase was evaluated. The results are shown in Fig.

도 3에서 나타나는 바와 같이, 물질 처리에 의해 티로시나아제의 발현이 감소함을 관찰하였다. 실시예 1의 경우, 비교예1에 비해 우수한 발현 억제 효능을 보였다. 그러므로, 본 실험을 통해, 정공실 발효물이 정공실 추출물보다 뛰어난 미백 효능을 가지고 있음을 증명하였다.As shown in Fig. 3, it was observed that the expression of tyrosinase was decreased by the treatment of the material. In the case of Example 1, the effect of suppressing the expression was better than that of Comparative Example 1. Therefore, through this experiment, it was proved that the fermentation product of the hole-spinning machine had better whitening effect than the extract of the hole-spinning machine.

실험예 5: 정공실 발효물에 의한 세포내 DCT 유전자 발현 측정EXPERIMENTAL EXAMPLE 5: Expression of DCT gene in cells by fermentation of a positive-working chamber

쥐의 색소세포(B16 melanoma cells)를 이용하여 비교예 1 및 실시예 1에 의한 멜라닌 생성기작에서 검은 유멜라닌 합성을 조절하는 인자인 DCT (dopachrome tautomerase)의 발현 억제효과를 확인하였다. The effect of inhibiting the expression of DCT (dopachrome tautomerase), which is a factor controlling the synthesis of melanin in the melanin of Comparative Example 1 and Example 1, was confirmed by using mouse pigment cells (B16 melanoma cells).

본 실험은 murine melanoma(B-16 F1) 세포를 10%의 FBS (fetal bovine serum)가 함유된 DMEM 배지로 6-well plate에 well 당 5×105 개로 접종한 후 5% CO2, 37℃ 하에서 세포가 well 바닥에 약 80 % 이상 부착될 때까지 배양하였다. 멜라닌 생성 유도를 위하여, 0.1 uM α-MSH를 처리하고, 이후 시료를 1% 첨가한 후 24시간 배양하였다. 양성대조군으로 알부틴 100 ppm 을 처리하였다. 배양한 세포는 phosphate buffered saline으로 씻고 1 ㎖ Trizol을 넣어 회수하였다. 0.2 ㎖ Chloroform(Trizol의 1/5 비율)을 넣어 voltexing 하여 4℃에서 14000 rpm, 15 분간 원심분리로 상층액을 얻었다. 동 상층액에 0.5 ㎖ isopropanol 넣고 10분간 반응시킨 후, 14000 rpm, 15 분간 원심분리하여 침전물을 얻었다. 상층액을 제거하고 200 ㎕ 100% EtOH를 이용하여 2회 씻어준다. 이후 침전물을 상온에서 완전히 말려 DEPC water 20~30 ㎕ 에 녹였다. DEPC에 녹인 RNA를 정량하여 각 그룹 당 RNA 동량을 사용하여 cDNA를 합성하였다. 합성된 cDNA를 타겟으로 시아닌 염료인 SYBR GREEN master mix 를 사용하여 실시간 중합효소 연쇄반응 (PCR)을 실시하여 최종적으로 MITF의 유전자 발현 정도를 평가하였다. 그 결과를 하기 도 4에 나타내었다. This experiment murine melanoma (B-16 F1) were inoculated the cells of 10% of FBS (fetal bovine serum) is the 6-well plate in the DMEM medium 5 × 10 5 pieces per well 5% CO 2, 37 ℃ Were cultured under the condition that the cells were attached to the bottom of the well by about 80% or more. For the induction of melanin production, 0.1 μM α-MSH was treated, followed by addition of 1% sample, followed by incubation for 24 hours. As a positive control, 100 ppm of arbutin was treated. The cultured cells were washed with phosphate buffered saline and recovered by adding 1 ml of Trizol. 0.2 ml Chloroform (1/5 ratio of Trizol) was added, and the supernatant was obtained by voltexing and centrifugation at 14000 rpm for 15 minutes at 4 ° C. 0.5 ml of isopropanol was added to the supernatant, followed by reaction for 10 minutes, followed by centrifugation at 14000 rpm for 15 minutes to obtain a precipitate. The supernatant is removed and washed twice with 200 μl of 100% EtOH. The precipitate was then completely dried at room temperature and dissolved in 20 to 30 μl of DEPC water. RNA was dissolved in DEPC and cDNA was synthesized using the same amount of RNA per group. Real-time PCR (PCR) was performed using SYBR GREEN master mix, which is a cyanine dye, with the synthesized cDNA as a target, and the degree of gene expression of MITF was finally evaluated. The results are shown in Fig.

도 4에서 나타나는 바와 같이, 물질 처리에 의해 DCT 전사인자의 발현이 감소함을 관찰하였다. 특히, 실시예 1의 경우, 비교예 1에 비해 우수한 발현 억제 효능을 보였다. 그러므로, 본 실험을 통해, 정공실 발효물이 정공실 추출물보다 뛰어난 미백 효능을 가지고 있음을 증명하였다.As shown in FIG. 4, it was observed that the expression of DCT transcription factor was reduced by the treatment of the material. Particularly, in Example 1, an excellent inhibitory effect was shown as compared with Comparative Example 1. Therefore, through this experiment, it was proved that the fermentation product of the hole-spinning machine had better whitening effect than the extract of the hole-spinning machine.

Claims (7)

정공실 추출물 또는 정공실 발효물을 유효성분으로 함유하는 피부 미백용 화장료 조성물.
A cosmetic composition for whitening skin, which contains an extract of a hole-sealing material or a fermentation product of a hole-sealing material as an active ingredient.
제 1항에 있어서, 상기 정공실 추출물은 물, 탄소수 1 내지 4의 저급알코올, 글리세린, 에틸아세테이트, 부틸렌글리콜, 프로필렌글리콜, 디클로로메탄 또는 핵산으로 추출하는 것을 특징으로 하는 피부 미백용 화장료 조성물.
2. The cosmetic composition for skin whitening according to claim 1, wherein the hole-extracting material is extracted with water, a lower alcohol having 1 to 4 carbon atoms, glycerin, ethyl acetate, butylene glycol, propylene glycol, dichloromethane or a nucleic acid.
제 1항에 있어서, 상기 정공실 발효물은 정공실 추출물을 유산균으로 발효한 것을 특징으로 하는 피부 미백용 화장료 조성물.
[Claim 7] The cosmetic composition for skin whitening according to claim 1, wherein the fermentation product is fermented with a lactic acid bacterium.
제 3항에 있어서, 상기 유산균은 락토바실러스(Lactobacillus sp.), 류코노스톡(Leuconostoc sp.) 또는 비피도박테리아(Bifidobacteria sp.)인 것을 특징으로 하는 피부 미백용 화장료 조성물.
The cosmetic composition for skin whitening according to claim 3, wherein the lactic acid bacterium is Lactobacillus sp., Leuconostoc sp. Or Bifidobacteria sp.
제 1항에 있어서, 상기 정공실 추출물 또는 정공실 발효물은 화장료 조성물 총 중량 대비 0.01 내지 90중량% 함유하는 것을 특징으로 하는 피부 미백용 화장료 조성물.
[Claim 2] The cosmetic composition for skin whitening according to claim 1, wherein the extract of the hole-sealing material or the fermentation product of the hole-sealing material comprises 0.01 to 90% by weight based on the total weight of the cosmetic composition.
제 1항에 있어서, 상기 정공실 추출물 또는 정공실 발효물은 티로시나아제(tyrosinase) 발현 억제 및 멜라닌 생합성을 억제함으로써 피부 미백효과를 나타내는 것을 특징으로 하는 피부 미백용 화장료 조성물.
[Claim 2] The cosmetic composition for skin whitening according to claim 1, wherein the extract of the positive-pressure chamber or the fermentation product of the positive-working chamber exhibits a skin whitening effect by inhibiting tyrosinase expression and inhibiting melanin biosynthesis.
제 1항에 있어서, 상기 조성물은 스킨로션, 스킨소프너, 스킨토너, 아스트린젠트, 로션, 밀크로션, 모이스쳐 로션, 영양로션, 맛사지크림, 영양크림, 모이스처크림, 핸드크림, 파운데이션, 에센스, 영양에센스, 팩, 비누, 클렌징폼, 클렌징로션, 클렌징크림, 바디로션 및 바디클렌저로 구성된 그룹에서 선택된 하나 이상의 제형인 것을 특징으로 하는 피부 미백용 화장료 조성물.The composition according to claim 1, wherein the composition is at least one selected from the group consisting of a skin lotion, a skin softener, a skin toner, an astringent, a lotion, a milk lotion, a moisturizing lotion, a nutrition lotion, a massage cream, a nutritional cream, a moisturizing cream, a hand cream, Wherein the at least one cosmetic composition is at least one selected from the group consisting of a pack, a soap, a cleansing foam, a cleansing lotion, a cleansing cream, a body lotion and a body cleanser.
KR1020160148855A 2016-11-09 2016-11-09 Cosmetic composition for whitening skin comprising extract of Sorbus aucuparia berry or fermented product of Sorbus aucuparia berry KR102211942B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020160148855A KR102211942B1 (en) 2016-11-09 2016-11-09 Cosmetic composition for whitening skin comprising extract of Sorbus aucuparia berry or fermented product of Sorbus aucuparia berry

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020160148855A KR102211942B1 (en) 2016-11-09 2016-11-09 Cosmetic composition for whitening skin comprising extract of Sorbus aucuparia berry or fermented product of Sorbus aucuparia berry

Publications (2)

Publication Number Publication Date
KR20180052157A true KR20180052157A (en) 2018-05-18
KR102211942B1 KR102211942B1 (en) 2021-02-04

Family

ID=62453756

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020160148855A KR102211942B1 (en) 2016-11-09 2016-11-09 Cosmetic composition for whitening skin comprising extract of Sorbus aucuparia berry or fermented product of Sorbus aucuparia berry

Country Status (1)

Country Link
KR (1) KR102211942B1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110478309A (en) * 2019-09-27 2019-11-22 无锡宾西利悦科技有限公司 A kind of composition of the shining face of tender skin
KR20220157589A (en) 2021-05-21 2022-11-29 (주)메디톡스 Composition Comprising Extracellular Vesicles Derived from Yeast, and methods related thereto
FR3123657A1 (en) * 2021-06-08 2022-12-09 Soredec - Societe De Recherches Et D'etudes Cosmetologiques PROTEIN HYDROLYZATE DERIVED FROM ROMAN BERRIES, COSMETIC COMPOSITION CONTAINING SUCH A HYDROLYZATE AND USE FOR MAINTAINING SKIN HYDRATION

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050007515A (en) * 2003-07-11 2005-01-19 주식회사 태평양 Phagocytosis inhibitor composition containing Sorbus commixta Hedl, Geranium nepalense, Betula pllatyphylla, Smilax glabra, Ephedrae Radix
KR20050110149A (en) 2004-05-18 2005-11-23 한불화장품주식회사 A cosmetic composition containing an extract of sorbus commixta
KR20130027117A (en) * 2011-09-07 2013-03-15 한불화장품주식회사 Cosmetic composition using microcapsules containing fermented herb medicine extracts
KR20160113435A (en) * 2015-03-20 2016-09-29 안동대학교 산학협력단 Pharmaceutical composition comprising the organic solvent fraction of sorbus commixta fruit as an effective component for prevention or treatment of thrombosis and health functional food comprising the same

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050007515A (en) * 2003-07-11 2005-01-19 주식회사 태평양 Phagocytosis inhibitor composition containing Sorbus commixta Hedl, Geranium nepalense, Betula pllatyphylla, Smilax glabra, Ephedrae Radix
KR20050110149A (en) 2004-05-18 2005-11-23 한불화장품주식회사 A cosmetic composition containing an extract of sorbus commixta
KR20130027117A (en) * 2011-09-07 2013-03-15 한불화장품주식회사 Cosmetic composition using microcapsules containing fermented herb medicine extracts
KR20160113435A (en) * 2015-03-20 2016-09-29 안동대학교 산학협력단 Pharmaceutical composition comprising the organic solvent fraction of sorbus commixta fruit as an effective component for prevention or treatment of thrombosis and health functional food comprising the same

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110478309A (en) * 2019-09-27 2019-11-22 无锡宾西利悦科技有限公司 A kind of composition of the shining face of tender skin
KR20220157589A (en) 2021-05-21 2022-11-29 (주)메디톡스 Composition Comprising Extracellular Vesicles Derived from Yeast, and methods related thereto
FR3123657A1 (en) * 2021-06-08 2022-12-09 Soredec - Societe De Recherches Et D'etudes Cosmetologiques PROTEIN HYDROLYZATE DERIVED FROM ROMAN BERRIES, COSMETIC COMPOSITION CONTAINING SUCH A HYDROLYZATE AND USE FOR MAINTAINING SKIN HYDRATION

Also Published As

Publication number Publication date
KR102211942B1 (en) 2021-02-04

Similar Documents

Publication Publication Date Title
KR20110098122A (en) Composition containing ginseng berry fermentation extract using bacteria
JP2017165727A (en) Composition and external preparation for skin
TW201206494A (en) Use of Tiliacora triandra in cosmetics and compositions thereof
CN111944870B (en) Phyllanthus emblica extract fermentation product and preparation and application thereof
KR102211942B1 (en) Cosmetic composition for whitening skin comprising extract of Sorbus aucuparia berry or fermented product of Sorbus aucuparia berry
JP2023171950A (en) Anti-aging agent, antioxidant, anti-inflammatory agent, and whitening agent, as well as cosmetic
KR20190063549A (en) Cosmetic Composition Comprising Bamboo Fermented Extract
KR102119524B1 (en) Cosmetic composition comprising the extract of fermented Sprout leaf/stem ginseng for skin anti-wrinkle effect and producing method thereof
KR20200015423A (en) Composition for skin whitening or anti-wrinkle comprising fermented extract of Ambrosia trifida and Annual fleabane
KR20220162666A (en) Composition for Skin Whitening, Moisturizing, Strengthening Skin Barrier, Skin Cell Regeneration, and Anti-Wrinkle Property Comprising Fermented Extract of Broussonetia kazinoki as Active Ingredient
KR20120117116A (en) Cosmetic compositions for preventing skin cell death comprising extracts of fermented red ginseng
KR102467931B1 (en) Brevibacillus borstelensis strain and its use for improving hair or scalp condition
KR102325393B1 (en) Skin whitening cosmetic composition with bioconversion of Breea segeta extract
KR102202554B1 (en) Skin whitening cosmetic composition with the extract of Saururus chinensis leaf, the extract of Grape seed, the extract of Portulaca oleracea and rice fermented product
KR20190037436A (en) Cosmetic composition including fermented water lily extract and method for manufacturing the same
KR20220077991A (en) Composition for anti-inflammation and anti-wrinkle comprising fermentative product of Gryllus bimaculatus extract as effective component
KR101994618B1 (en) A composition for skin smoothing comprising an extract of fermented ponciri fructus
KR20120118946A (en) Skin whitening complex containing trihydroxyisoflavone and glycyrrhiza uralensis extracts
KR20210047588A (en) Skin-lightening Composition Using an Extract of Xanthium canadense
KR20110069541A (en) Skin-whitening composition containing lactone as an active ingredien
KR20210025316A (en) Composition for improving skin beauty comprising extract of fermented roots of Panax notoginseng by Aspergillus cristatus strain
KR102495402B1 (en) Burkholderia vietnamiensis strain and its use for improving hair or scalp condition
KR102613802B1 (en) Composition for skin whitening comprising culture of Lactobacillus reuteri and extract of Cnidium Monnieri
KR102642545B1 (en) Composition for improving skin wrinkles and elasticity containing fermented ginseng sprouts as an active ingredient
KR102495399B1 (en) Gordonia terrae strain and its use for improving hair or scalp condition

Legal Events

Date Code Title Description
E701 Decision to grant or registration of patent right
GRNT Written decision to grant